48,830
edits
m |
m (replace DCHH) |
||
Line 172: | Line 172: | ||
===Epidemiology=== | ===Epidemiology=== | ||
*Female>male (~9:1).<ref>DCHH | *Female>male (~9:1).<ref>{{Ref DCHH|162}}</ref> | ||
*Usually middle age. | *Usually middle age. | ||
*Associated with other autoimmune conditions (Sjogren's syndrome, progressive systemic sclerosis, celiac). | *Associated with other autoimmune conditions (Sjogren's syndrome, progressive systemic sclerosis, celiac). | ||
Line 203: | Line 203: | ||
*[http://www.gidesigns.net/images/MC-copper-flower-garland-L.jpg Garland - wreath of flowers (gidesigns.net)]. | *[http://www.gidesigns.net/images/MC-copper-flower-garland-L.jpg Garland - wreath of flowers (gidesigns.net)]. | ||
DDx:<ref>DCHH | DDx:<ref>{{Ref DCHH|163}}</ref> | ||
*Sarcoidosis (if granulomas present). | *Sarcoidosis (if granulomas present). | ||
*PSC, viral hepatitis, AIH, drugs, Hodgkin's lymphoma<ref name=pmid19131796>Vanishing bile duct syndrome and Hodgkin disease: a case series and review of the literature. Pass AK, McLin VA, Rushton JR, Kearney DL, Hastings CA, Margolin JF. J Pediatr Hematol Oncol. 2008 Dec;30(12):976-80. PMID 19131796.</ref> | *PSC, viral hepatitis, AIH, drugs, Hodgkin's lymphoma<ref name=pmid19131796>Vanishing bile duct syndrome and Hodgkin disease: a case series and review of the literature. Pass AK, McLin VA, Rushton JR, Kearney DL, Hastings CA, Margolin JF. J Pediatr Hematol Oncol. 2008 Dec;30(12):976-80. PMID 19131796.</ref> | ||
Line 345: | Line 345: | ||
Microscopic: | Microscopic: | ||
*Non-specific findings. | *Non-specific findings. | ||
**+/-Eosinophils.<ref>DCHH | **+/-Eosinophils.<ref>{{Ref DCHH|166}}</ref> | ||
**+/-Steatosis - periportal macrovesicular, microvesicular. | **+/-Steatosis - periportal macrovesicular, microvesicular. | ||
edits